SENP1 and type 2 diabetes mellitus: This is complemented by Ferdaoussi and colleagues’ demonstration of how isocitrate influences Sentrin-specific protease 1 (SENP1) signaling with NADPH’s assistance, significantly increasing insulin secretion and presenting a promising target for T2DM therapy [75].